234 related articles for article (PubMed ID: 9372921)
1. Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment.
Xiao H; Lis JT; Jeang KT
Mol Cell Biol; 1997 Dec; 17(12):6898-905. PubMed ID: 9372921
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation.
Majello B; Napolitano G; Lania L
AIDS; 1998 Oct; 12(15):1957-64. PubMed ID: 9814863
[TBL] [Abstract][Full Text] [Related]
3. Recruitment of human TBP selectively activates RNA polymerase II TATA-dependent promoters.
Majello B; Napolitano G; De Luca P; Lania L
J Biol Chem; 1998 Jun; 273(26):16509-16. PubMed ID: 9632719
[TBL] [Abstract][Full Text] [Related]
4. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo.
Veschambre P; Simard P; Jalinot P
J Mol Biol; 1995 Jul; 250(2):169-80. PubMed ID: 7608968
[TBL] [Abstract][Full Text] [Related]
5. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
Ghosh S; Selby MJ; Peterlin BM
J Mol Biol; 1993 Dec; 234(3):610-9. PubMed ID: 8254663
[TBL] [Abstract][Full Text] [Related]
6. Transactivation activity of the human cytomegalovirus IE2 protein occurs at steps subsequent to TATA box-binding protein recruitment.
Kim JM; Hong Y; Jeang KT; Kim S
J Gen Virol; 2000 Jan; 81(Pt 1):37-46. PubMed ID: 10640540
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of TBP or TFIIB to a promoter proximal position leads to stimulation of RNA polymerase II transcription without activator proteins both in vivo and in vitro.
Huh JR; Park JM; Kim M; Carlson BA; Hatfield DL; Lee BJ
Biochem Biophys Res Commun; 1999 Mar; 256(1):45-51. PubMed ID: 10066420
[TBL] [Abstract][Full Text] [Related]
8. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
9. Recruiting TATA-binding protein to a promoter: transcriptional activation without an upstream activator.
Xiao H; Friesen JD; Lis JT
Mol Cell Biol; 1995 Oct; 15(10):5757-61. PubMed ID: 7565728
[TBL] [Abstract][Full Text] [Related]
10. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
[TBL] [Abstract][Full Text] [Related]
11. Identification of limiting steps for efficient trans-activation of HIV-1 promoter by Tat in Saccharomyces cerevisiae.
Daviet L; Bois F; Battisti PL; Gatignol A
J Biol Chem; 1998 Oct; 273(43):28219-28. PubMed ID: 9774443
[TBL] [Abstract][Full Text] [Related]
12. The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes.
Ohana B; Moore PA; Ruben SM; Southgate CD; Green MR; Rosen CA
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):138-42. PubMed ID: 8419915
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs.
Raha T; Cheng SW; Green MR
PLoS Biol; 2005 Feb; 3(2):e44. PubMed ID: 15719058
[TBL] [Abstract][Full Text] [Related]
14. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
15. Gal4-VP16 and Gal4-AH increase the orientational and axial specificity of TATA box recognition by TATA box binding protein.
Kays AR; Schepartz A
Biochemistry; 2002 Mar; 41(9):3147-55. PubMed ID: 11863454
[TBL] [Abstract][Full Text] [Related]
16. Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators.
Kamine J; Subramanian T; Chinnadurai G
J Virol; 1993 Nov; 67(11):6828-34. PubMed ID: 8411386
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner.
Suñé C; Garcia-Blanco MA
Mol Cell Biol; 1999 Jul; 19(7):4719-28. PubMed ID: 10373521
[TBL] [Abstract][Full Text] [Related]
18. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
20. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
Rhim H; Rice AP
Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
